443 filings
Page 4 of 23
SC 13D/A
fzolk xl9h
14 Feb 23
Cellectis / Bpifrance Participations ownership change
12:34pm
6-K
z7j8 ozj20v7
8 Feb 23
Current report (foreign)
8:10am
6-K
tujflwfo74zuhycgcxk9
7 Feb 23
Cellectis Announces Closing of Global Offering and Exercise of Underwriters’ Option to Purchase Additional Shares
7:09pm
6-K
cimnb8mh0rlh37tkpf
7 Feb 23
Current report (foreign)
6:28am
424B5
8wiewuvjpu
3 Feb 23
Prospectus supplement for primary offering
4:01pm
6-K
58efro
3 Feb 23
Cellectis Supplements the Announcement of the Pricing of Follow-On Offering with Allocation of Share Capital Information
10:10am
6-K
g81l0f1 slbbv
3 Feb 23
Cellectis Announces Pricing of Follow-On Offering
6:50am
6-K
lkm0svy2 jcxr5
2 Feb 23
Cellectis Announces Launch of Follow-On Offering
4:12pm
424B5
6frlalcc
2 Feb 23
Prospectus supplement for primary offering
4:02pm
6-K
sixn5qq
20 Jan 23
Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeutics
4:36pm
SC 13G/A
o8jdfpv bp7ircz
18 Jan 23
Cellectis / BAILLIE GIFFORD & CO ownership change
10:03am
SC 13D/A
he3goe3hzv
17 Jan 23
Calyxt / Cellectis ownership change
4:08pm
6-K
jc8isro17q7p8abq5
17 Jan 23
Current report (foreign)
4:05pm
6-K
73sc jcbbcapjl7y
17 Jan 23
Calyxt and Cibus Announce the Signing of a Definitive Merger Agreement
7:16am
FWP
chgqu2gs8zlqqd1en8m
4 Jan 23
Free writing prospectus
5:16pm
6-K
7ojwwqoi2pg3hxw5y
4 Jan 23
Current report (foreign)
5:13pm
6-K
gx9 tfehrv
4 Jan 23
Current report (foreign)
5:04pm
424B5
6ahbad45
4 Jan 23
Prospectus supplement for primary offering
4:59pm
6-K
bwhvj8gh2x1va23ho2zl
4 Jan 23
Current report (foreign)
4:24pm
6-K
smo tcrhj6v0dfk2ravo
4 Jan 23
Current report (foreign)
4:21pm